Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)

Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)

Background: The population of interest to this study comprised individuals with advanced-stage ovarian carcinoma who were exposed to neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS). Those who had not received systematic lymphadenectomy (SL; Group 1) were compared to those...

Full description

Bibliographic Details
Main Authors: Virginie Bund, Lise Lecointre, Michel Velten, Lobna Ouldamer, Sofiane Bendifallah, Martin Koskas, Pierre-Adrien Bolze, Pierre Collinet, Geoffroy Canlorbe, Cyril Touboul, Cyrille Huchon, Charles Coutant, Emilie Faller, Thomas Boisramé, Justine Gantzer, Martin Demarchi, Jean-Jacques Baldauf, Marcos Ballester, Vincent Lavoué, Chérif Akladios
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
ovarian carcinoma
neoadjuvant chemotherapy
systematic lymphadenectomy
Online Access:https://www.mdpi.com/2077-0383/9/8/2427

Internet

https://www.mdpi.com/2077-0383/9/8/2427

Similar Items